SEPTIC-ED: Sepsis Electronic Prompting for Timely Intervention and Care for Emergency Department Patients
Study Details
Study Description
Brief Summary
The goal of this clinical trial is to study systemic inflammatory response syndrome (SIRS) electronic health record (EHR) alerts for sepsis in the emergency department (ED). The main question it aims to answer is: do nurse alerts, prescribing clinician alerts, or both nurse and prescribing clinician alerts improve time to sepsis treatment for patients in the ED?
Nurses and prescribing clinicians will receive SIRS alerts based on the group to which the patient is randomly assigned. Researchers will compare four groups: no alerts, nurse alerts only, prescribing clinician alerts only, or both nurse and prescribing clinician alerts.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
SEPTIC is a master protocol for two trials on distinct subpopulations: emergency department (ED) patients and inpatients. This protocol "ID: AAAU1002 - ED" describes the ED subpopulation study while "ID: AAAU1002 - IP" describes the inpatient subpopulation study.
Sepsis is a major cause of death both globally and in the United States. Early identification and treatment of sepsis are crucial for improving outcomes. International guidelines recommend hospital sepsis screening programs, which are commonly implemented in the electronic health record (EHR) as an interruptive screening alert based on systemic inflammatory response syndrome (SIRS) criteria. Despite widespread use, it is unknown whether these sepsis screening and alert tools improve the delivery of high-quality sepsis care. This study tests interruptive (pop-up) EHR alerts. Epic Systems, the company that produces the EHR, refers to these types of alerts as BestPractice Advisories (BPAs).
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
No Intervention: No alert Participants will receive no physician alert or registered nurse (RN) alert. |
|
Experimental: Nurse alert Participants will receive RN alert. |
Other: Nurse SIRS alert
An electronic alert will display when a nurse opens the patient chart of a patient who meets SIRS criteria.
|
Experimental: Prescribing clinician alert Participants will receive physician alert. |
Other: Prescribing clinician SIRS alert
An electronic alert will display when a prescribing clinician opens the patient chart of a patient who meets SIRS criteria.
|
Experimental: Nurse alert and prescribing clinician alert Participants will receive physician alert and RN alert. |
Other: Nurse SIRS alert
An electronic alert will display when a nurse opens the patient chart of a patient who meets SIRS criteria.
Other: Prescribing clinician SIRS alert
An electronic alert will display when a prescribing clinician opens the patient chart of a patient who meets SIRS criteria.
|
Outcome Measures
Primary Outcome Measures
- Percentage of patients treated with Surviving Sepsis Campaign (SSC) hour-1 bundle [Up to 3 hours]
The primary outcome is whether a patient receives a modified SSC hour-1 bundle within three hours from the time of first SIRS alert. The modified SSC hour-1 bundle includes (1) lactate lab collected, (2) two blood cultures collected, (3) new intravenous antimicrobial administration (from the Centers for Disease Control and Prevention (CDC) Adult Sepsis Event (ASE) list). Patients will be tallied.
Secondary Outcome Measures
- Time to blood culture order [24 hours]
Time from the first SIRS alert until two blood cultures ordered in all patients and the subgroups of patients with CDC ASE, CDC BSE, and Sepsis-3 sepsis definitions. This will be measured in minutes.
- Time to blood culture collection [24 hours]
Time from the first SIRS alert until two blood cultures collected in all patients and the subgroups of patients with CDC ASE, CDC BSE, and Sepsis-3 sepsis definitions. This will be measured in minutes.
- Time to lactate order [24 hours]
Time from the first SIRS alert until lactate lab ordered in all patients and the subgroups of patients with CDC ASE, CDC BSE, and Sepsis-3 sepsis definitions. This will be measured in minutes.
- Time to lactate collection [24 hours]
Time from the first SIRS alert until lactate lab collected in all patients and the subgroups of patients with CDC ASE, CDC BSE, and Sepsis-3 sepsis definitions. This will be measured in minutes.
- Time to antibiotic order [24 hours]
Time from the first SIRS alert until new antibiotic order in all patients and the subgroups of patients with CDC ASE, CDC BSE, and Sepsis-3 sepsis definitions. This will be measured in minutes.
- Time to antibiotic treatment [24 hours]
Time from the first SIRS alert until new antibiotic administration in all patients and the subgroups of patients with CDC ASE, CDC BSE, and Sepsis-3 sepsis definitions. This will be measured in minutes.
- Sepsis incidence [Up to 90 days]
Sepsis incidence (CDC ASE, CDC BSE, Sepsis-3) across all alerting groups. Events will be recorded and tallied up to 90 days from first SIRS alert or discharge, whichever occurs first.
- Percentage of patients transferred to ICU transfer [Up to 90 days]
Intensive care unit (ICU) transfers for patients not in the ICU at the time of first SIRS alert will be recorded and tallied up to 90 days from first SIRS alert or discharge, whichever occurs first.
- Median number of days of hospitalization [Up to 90 days]
This is to determine the average length of stay in the hospital. Days will be recorded and tallied up to 90 days from first SIRS alert or discharge, whichever occurs first.
- Percentage of patients discharged as deceased or discharged to hospice [Up to 90 days]
This is to measure the outcomes ended in death or hospice. Outcomes will be recorded and tallied up to 90 days from first SIRS alert or discharge, whichever occurs first.
- Percentage of patients discharged home [Up to 90 days]
This is to measure the outcomes ended in returning to home. Outcomes will be recorded and tallied up to 90 days from first SIRS alert or discharge, whichever occurs first.
- Percentage of patients discharged to rehab [Up to 90 days]
This is to measure the outcomes ended in rehab. Outcomes will be recorded and tallied up to 90 days from first SIRS alert or discharge, whichever occurs first.
- Percentage of patients discharged to skilled nursing facility [Up to 90 days]
This is to measure the outcomes ended in skilled nursing facility. Outcomes will be recorded and tallied up to 90 days from first SIRS alert or discharge, whichever occurs first.
- Percentage inpatient mortality at 90 days [Up to 90 days]
This is to measure inpatient mortality. Deaths will be recorded and tallied up to 90 days from first SIRS alert or discharge, whichever occurs first.
- Number of positive blood cultures [Up to 90 days]
Positive blood cultures will be determined by blood tests. Positive cultures will be recorded and tallied up to 90 days from first SIRS alert or discharge, whichever occurs first.
- Adverse antibiotic events [Up to 90 days]
This is defined as new antibiotic allergy documented in 14 days after first SIRS alert or C. difficile infection or multi-drug resistant organism infection within 7-90 days of first SIRS alert. Events will be recorded and tallied up to 90 days from first SIRS alert or discharge, whichever occurs first.
- Time to modified SSC hour-1 bundle completion [24 hours]
Time interval from first SIRS alert to a modified SSC hour-1 bundle completion, censored at 24 hours after the first alert time, in all patients and the subgroups of patients with CDC ASE, CDC Bacteraemia/Fungemia Shock Event (BSE), and Sepsis-3 sepsis definitions. This will be measured in minutes.
Eligibility Criteria
Criteria
Patient Inclusion Criteria:
-
age > 18 years-old
-
meets SIRS criteria
-
physically located in the emergency department
-
not located in a hospital unit that takes care of pregnant and peri-partum patients
-
not SARS-COV-2 PCR positive in past 7 days
-
does not have an active order for "comfort measures only"
Patient Exclusion Criteria:
-
already having sepsis treatment ordered (if prescribing clinician alert) or collected/completed (if nurse alert)
-
already enrolled in the SEPTIC study (including as an emergency department patient or as an inpatient)
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | NewYork-Presbyterian Hospitals | New York | New York | United States | 10032 |
Sponsors and Collaborators
- Columbia University
Investigators
- Study Director: Benjamin L Ranard, MD, MSHP, Columbia University
- Principal Investigator: Jason S Adelman, MD, MS, Columbia University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- AAAU1002 - ED